EGMN -- Insurance payers now have detailed guidance on the appropriate use and coverage of biologic agents in the management of rheumatoid arthritis, thanks to a document prepared by the American College of Rheumatology.
EGMN -- Insurance payers now have detailed guidance on the appropriate use and coverage of biologic agents in the management of rheumatoid arthritis, thanks to a document prepared by the American College of Rheumatology.